I
IxLayer
Biotech & Life Sciences · San Francisco, United States · Founded 2017
Digital health company focused on improving the delivery of lab testing MoreLess
Ixlayer is a healthcare technology startup that provides diagnostic laboratory testing solutions for a variety of clients including health plans, retailers, and biopharma companies. The company operates in the healthcare market, specifically in the diagnostic testing sector, and aims to make diagnostic testing more accessible and affordable.
Ixlayer's business model revolves around offering fully integrated, custom solutions that enable clients to offer a personalized healthcare experience. They have powered over 1,100 nationwide programs and millions of diagnostic tests annually. Their services include providing custom test kits, lab services, reporting, and health maintenance.
The company generates revenue by offering these services to their clients. Health plans use ixlayer's white-labeled kits and cloud-based platform to close gaps in care. Retailers, such as pharmacies, use ixlayer's solutions to bring diagnostic testing products, preventive health, and wellness programs to market faster and manage them more efficiently. Biopharma companies leverage ixlayer's ecosystem to maximize therapeutic and commercial success.
Ixlayer's technology ensures a precise and secure flow of information, as well as an engaging and delightful patient or consumer experience. The company has also played a significant role in mitigating the spread of COVID-19 by providing a testing platform for the United States Coast Guard.
Keywords: Healthcare Technology, Diagnostic Laboratory Testing, Custom Solutions, Health Plans, Retailers, Biopharma Companies, Test Kits, Lab Services, Reporting, Health Maintenance.
Company overview
IxLayer company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2017
- Headquarters
- San Francisco, United States
- Employees
- 40
- Open positions
- None listed
- Dealroom signal
- 66.2
Valuation & funding
IxLayer funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VCOther financing | Aug 2021 | $0 | — | Salesforce Ventures · Accenture Ventures | — |
| SERIES AOther financing | Mar 2021 | $75M | $300M | Zeshan Muhammedi · Pear Ventures · Dara Khosrowshahi · General Catalyst | — |
| EARLY VCOther financing | Sep 2019 | $0 | — | FundRx | — |
| FundingOther financing | Sep 2019 | $0 | — | Pear Ventures | — |
| FundingOther financing | Jun 2019 | $0 | — | Village Global | — |
| SEEDOther financing | May 2018 | Plug and Play | — |
Growth signals
IxLayer website traffic
Latest recorded traffic for IxLayer is 3.2K monthly website visits, up 88.2% over the last three months. IxLayer's team grew 0% over the past year.
Comparisons
IxLayer compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
IxLayer's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where IxLayer has talent and traffic
team presence
In the news
Latest news about IxLayer
Recent press, funding announcements, and product moves mentioning IxLayer — open to read from the original sources.
Market sentiment
What the market is saying about IxLayer
An AI-synthesized read of the highest-engagement posts about IxLayer on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See IxLayer’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.